Eating walnuts regularly does not appear to lower the risk of dying from cancer in older adults, even though walnuts contain compounds that might theoretically affect cancer cells.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A meta-analysis of RCTs would determine whether walnut supplementation reduces cancer mortality across diverse populations, resolving inconsistencies in observational data.
A systematic review and meta-analysis of at least 10 RCTs with 500+ participants each, aged 55–75, randomized to 28–56 g/day walnuts vs. placebo for 5+ years, with cancer mortality as primary endpoint and adjudicated by blinded reviewers.
A long-term RCT would determine whether daily walnut intake directly reduces cancer mortality by isolating its effect from confounding factors.
A double-blind, placebo-controlled RCT of 5,000 adults aged 60–75, randomized to consume 56 g of walnuts daily or a calorie-matched snack for 10 years, with cancer mortality as primary endpoint and cancer diagnoses confirmed by pathology reports.
A prospective cohort with repeated dietary assessments can determine whether walnut intake predicts cancer mortality over decades.
A prospective cohort of 100,000 U.S. adults aged 55–75, with walnut intake assessed every 2 years via FFQ and biomarkers, followed for 30+ years with cancer mortality tracked via national registries, adjusting for smoking, BMI, and family history.
A case-control study could compare walnut intake patterns in individuals who died of cancer versus those who survived, identifying dietary patterns linked to cancer mortality.
A matched case-control study of 2,000 adults aged 60+ who died of cancer (cases) and 2,000 survivors (controls), with detailed dietary recall for the 5 years prior to death or censoring, controlling for smoking, alcohol, and physical activity.
A cross-sectional survey could correlate walnut consumption with cancer biomarkers at a single point in time, but cannot determine if intake preceded cancer development.
A national survey of 15,000 U.S. adults aged 60+ measuring walnut intake via 24-hour recall and biomarkers (e.g., inflammatory markers, oxidative stress) in a single visit, adjusting for socioeconomic status and chronic disease history.